BTX-A51 treatment modulates host innate immune responses via NF-κB and β-catenin signaling during Rift Valley fever virus infection in vitro

{"Rift":[0],"Valley":[1,246],"fever":[2,247],"virus":[3,56,248],"(RVFV)":[4,249],"is":[5,32,250,289],"a":[6,40,102,170,216,233,251,290,327,381],"zoonotic":[7,252],"and":[8,31,50,69,96,153,159,177,192,210,221,253,262,269,298,307,312,334,343],"mosquito-borne":[9,254],"hemorrhagic":[10],"pathogen":[11,42,255],"of":[12,54,72,87,109,148,156,256,325,357],"high":[13,257],"pandemic":[14,258,384],"potential,":[15],"endemic":[16],"to":[17,34,59,63,105,150,272,330,346,354,374],"most":[18,23],"countries":[19],"in":[20,27,111,134,169,173,295,300,317,350],"Africa.":[21],"It":[22],"severely":[24],"causes":[25],"disease":[26],"small":[28],"domestic":[29],"ruminants":[30,261],"transmitted":[33],"humans.":[35,263],"RVFV":[36,117,208,225],"has":[37],"been":[38],"declared":[39],"priority":[41],"by":[43,130],"the":[44,64,83,107,135,151,165,219,275,323,341,362,369],"World":[45],"Health":[46],"Organization":[47],"for":[48,82,141,236,281,371,383],"vaccine":[49],"therapeutic":[51,238],"development.":[52],"Outbreaks":[53],"this":[55,145],"are":[57,315],"known":[58,280],"cause":[60,266],"great":[61,267],"disturbances":[62],"economy,":[65],"agriculture,":[66],"food":[67],"availability,":[68],"healthcare":[70],"system":[71],"local":[73],"communities.":[74],"No":[75],"U.S.":[76],"FDA-approved":[77],"vaccines":[78],"or":[79,85],"therapeutics":[80],"exist":[81],"prevention":[84],"treatment":[86,163,184,373],"RVFV.":[88],"Here,":[89],"we":[90],"used":[91],"BTX-A51,":[92,326],"an":[93],"anticancer":[94],"drug":[95],"casein":[97],"kinase-1":[98],"(CK1)":[99,288],"inhibitor,":[100,329],"as":[101,232,304,380],"pharmacological":[103],"tool":[104,382],"investigate":[106],"role":[108],"CK1":[110,123,139,204,328],"regulating":[112],"innate":[113,212],"immune":[114,213],"signaling":[115,129,231,314,349],"during":[116,224],"infection.":[118,226],"The":[119],"results":[120],"show":[121],"that":[122,137,203],"inhibition":[124,205],"via":[125],"BTX-A51":[126,162,183,337,372],"dampened":[127],"NF-κB-mediated":[128,305],"blocking":[131],"different":[132,378],"steps":[133],"cascade":[136],"require":[138],"phosphorylation":[140],"signal":[142],"progression.":[143],"Consequently,":[144],"reduced":[146],"translocation":[147],"p65":[149],"nucleus":[152],"transcriptional":[154],"activation":[155],"pro-inflammatory":[157],"cytokines":[158],"enzymes.":[160],"Additionally,":[161],"influenced":[164],"β-catenin":[166,174,178,222,308,313,344],"pathway,":[167],"resulting":[168],"significant":[171],"increase":[172],"protein":[175],"levels":[176],"colocalization":[179],"with":[180],"p65.":[181],"Delayed":[182],"retained":[185],"its":[186,282],"impact":[187],"on":[188,340],"cytokine":[189],"gene":[190],"expression":[191],"partially":[193],"rescued":[194],"cells":[195,297],"from":[196],"RVFV-induced":[197],"cell":[198],"death.":[199],"Our":[200],"data":[201],"suggest":[202],"influences":[206],"both":[207],"replication":[209,333],"host":[211,291],"signaling,":[214],"suggesting":[215],"relationship":[217],"between":[218],"NF-κB":[220,311,342],"pathways":[223,345],"These":[227],"findings":[228,366],"identify":[229],"CK1-mediated":[230],"potential":[234,370],"target":[235],"host-directed":[237],"strategies":[239],"aimed":[240],"at":[241],"limiting":[242],"excessive":[243],"virus-induced":[244],"inflammation.IMPORTANCERift":[245],"risk,":[259],"affecting":[260],"Disease":[264],"outbreaks":[265],"health":[268],"economic":[270],"disruptions":[271],"communities":[273],"across":[274,361],"African":[276],"continent,":[277],"being":[278,359],"famously":[279],"\\"abortion":[283],"storms.\\"":[284],"Casein":[285],"kinase":[286,292],"1":[287],"ubiquitously":[293],"present":[294],"eukaryotic":[296],"involved":[299],"multiple":[301],"pathways,":[302],"such":[303],"inflammation":[306],"signaling.":[309,336],"Both":[310],"altered":[316],"RVFV-infected":[318,351],"cells.":[319,352],"This":[320],"manuscript":[321],"tests":[322],"ability":[324],"limit":[331],"viral":[332],"inflammatory":[335],"acted":[338],"concomitantly":[339],"reduce":[347],"proinflammatory":[348],"Due":[353],"many":[355],"mechanisms":[356],"infection":[358],"conserved":[360],"Bunyavirales":[363],"order,":[364],"these":[365],"also":[367],"create":[368],"be":[375],"tested":[376],"against":[377],"viruses":[379],"preparedness.":[385]}

Authors

Institutions

Publication Details

Journal
Journal of Virology
Published
2026-09-09
DOI
https://doi.org/10.1128/jvi.01042-26
Primary Topic
Viral Infections and Vectors
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

BTX-A51 treatment modulates host innate immune responses via NF-κB and β-catenin signaling during Rift Valley fever virus infection in vitro

Kylene Kehn‐Hall, Timothy Stocker, Rafaela Flor, Maryna Akhrymuk et al.
Journal of Virology
Viral Infections and Vectors
article

BTX-A51 treatment modulates host innate immune responses via NF-κB and β-catenin signaling during Rift Valley fever virus infection in vitro

Kylene Kehn‐Hall, Timothy Stocker, Rafaela Flor, Maryna Akhrymuk, Kaylee Petraccione, Caitlin Woodson, Ivan Akhrymuk, Brittany N. Heath
article en

Abstract

Rift Valley fever virus (RVFV) is a zoonotic and mosquito-borne hemorrhagic pathogen of high pandemic potential, endemic to most countries in Africa. It most severely causes disease in small domestic ruminants and is transmitted to humans. RVFV has been declared a priority pathogen by the World Health Organization for vaccine and therapeutic development. Outbreaks of this virus are known to cause great disturbances to the economy, agriculture, food availability, and healthcare system of local communities. No U.S. FDA-approved vaccines or therapeutics exist for the prevention or treatment of RVFV. Here, we used BTX-A51, an anticancer drug and casein kinase-1 (CK1) inhibitor, as a pharmacological tool to investigate the role of CK1 in regulating innate immune signaling during RVFV infection. The results show that CK1 inhibition via BTX-A51 dampened NF-κB-mediated signaling by blocking different steps in the cascade that require CK1 phosphorylation for signal progression. Consequently, this reduced translocation of p65 to the nucleus and transcriptional activation of pro-inflammatory cytokines and enzymes. Additionally, BTX-A51 treatment influenced the β-catenin pathway, resulting in a significant increase in β-catenin protein levels and β-catenin colocalization with p65. Delayed BTX-A51 treatment retained its impact on cytokine gene expression and partially rescued cells from RVFV-induced cell death. Our data suggest that CK1 inhibition influences both RVFV replication and host innate immune signaling, suggesting a relationship between the NF-κB and β-catenin pathways during RVFV infection. These findings identify CK1-mediated signaling as a potential target for host-directed therapeutic strategies aimed at limiting excessive virus-induced inflammation.IMPORTANCERift Valley fever virus (RVFV) is a zoonotic and mosquito-borne pathogen of high pandemic risk, affecting ruminants and humans. Disease outbreaks cause great health and economic disruptions to communities across the African continent, being famously known for its "abortion storms." Casein kinase 1 (CK1) is a host kinase ubiquitously present in eukaryotic cells and involved in multiple pathways, such as NF-κB-mediated inflammation and β-catenin signaling. Both NF-κB and β-catenin signaling are altered in RVFV-infected cells. This manuscript tests the ability of BTX-A51, a CK1 inhibitor, to limit viral replication and inflammatory signaling. BTX-A51 acted concomitantly on the NF-κB and β-catenin pathways to reduce proinflammatory signaling in RVFV-infected cells. Due to many mechanisms of infection being conserved across the Bunyavirales order, these findings also create the potential for BTX-A51 treatment to be tested against different viruses as a tool for pandemic preparedness.

Journal of Virology
National Center for Emerging and Zoonotic Infectious Diseases (US), Virginia Tech (US)
Openalex Percentile: Top 11%
Viral Infections and Vectors
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.